• Schumann C, Nguyen D, Nogard M, Bortnyak Y, Korzan T, Chan S, Lorenz A, Moses A, Albaraui H, Wong L Michaelis K, Zhu X, Alani A, Taratula O, Kransnow S, Marks D, Taratula R. Increasing lean muscle mass in mice via nanoparticle-mediated hepatic delivery of follistatin mRNA. Theranostics 2018; 8(19):5276-5288.

  • Brady JV, Troyer RM, Ramsey SA, Leeper H, Yang L, Maier CS, Goodall CP, Ruby CE, Albarqi HAM, Taratula O, Bracha S. A Preliminary Proteomic Investigation of Circulating Exosomes and Discovery of Biomarkers Associated with the Progression of Osteosarcoma in a Clinical Model of Spontaneous Disease. Transl Oncol. 2018,11(5):1137-1146. 
  • Schumann C, Chan S, Millar JA, Bortnyak Y, Carey K, Fedchyk A, Wong L, Korzun T, Moses AS, Lorenz A, Shea D, Taratula O, Khalimonchuk O, Taratula O. Intraperitoneal nanotherapy for metastatic ovarian cancer based on siRNA-mediated suppression of DJ-1 protein combined with a low dose of cisplatin. Nanomedicine. 2018, 14(4):1395-1405
  • Li X, Schumann C, Albarqi HA, Lee CJ, Alani AWG, Bracha S, Milovancev M, Taratula O, Taratula O. A Tumor-Activatable Theranostic Nanomedicine Platform for NIR Fluorescence-Guided Surgery and Combinatorial Phototherapy. Theranostics. 2018, 8(3):767-784
  • Duong T, Li X, Yang B, Schumann C, Albarqi HA, Taratula O, Taratula O. Phototheranostic Nanoplatform Based in a Single Cyanine Dye for Image-Guided Combinatorial Phototherapy. Nanomedicine. 2017, Apr;13(3):955-963
  • Troyer RM, Ruby CE, Goodall CP, Yang L, Maier CS, Albarqi HA, Brady JV, Bathke K, Taratula O, Mourich D, Bracha S. Exosomes from Osteosarcoma and normal osteoblast differ in proteomic cargo and immunomodulatory effects on T cells. Exp Cell Res. 2017, 358(2):369-376.
  • Goloviznina NA, Verghese SC, Yoon YM, Taratula O, Marks DL, Kurre P. Mesenchymal stromal cell-derived extracellular vesicles promote myeloid-biased multipotent hematopoietic progenitor expansion via Toll-like receptor engagement. J Biol Chem. 2017, 292(8):3541
  • Li, X.; Taratula, O.; Taratula, O. R.; Schumann, C.; Minko, T. LHRH-Targeted Drug Delivery Systems for Cancer Therapy. Mini-Reviews in Medicinal Chemistry. 2016 In Press.
  • Taratula, O. R.; Doddapaneni, B. S.; Schumann, C.; Li, X.; Bracha, S.; Milovancev, M.; Alani, A. W. G.; Taratula O. Naphthalocyanine-Based Biodegradable Polymeric Nanoparticles for Image-Guided Combinatorial Phototherapy. Chem. Mater. 2015, 27, 6155-6165
  • Taratula OR, Schumann C, Duong T, Taylor KL, and Taratula O. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy. Nanomedicine: Nanotechnology, Biology, and Medicine 2015, 11(8), 1961-1970
  • Taratula, O. R.; Duong, T.; Schumann, C.; Taratula O. Dendrimer-encapsulated naphthalocyanine as a single agent-based theranostic nanoplatform for near-infrared fluorescence imaging and combinatorial anticancer phototherapy. Nanoscale 2015, 7, 3888-3902.
  • Taratula, O. R.; Patel, M.; Schumann, C.; Naleway, M. A.; Pang, A. J.; He, H.; Taratula O. Phthalocyanine-loaded graphene nanoplatform for imaging-guided combinatorial phototherapy. Int. J. Nanomed. 2015, 10, 2347-2362.
  • Dani, R. K.; Schumann, C.; Taratula, O. R.; Taratula, O. Temperature-Tunable Iron Oxide Nanoparticles for Remote-Controlled Drug Release. AAPS PharmaSciTech, 2014, 4, 963-972.
  • Taratula, O. R.; Dani, R. K.; Schumann, C.; Xub, H.; Wang, A.; Song, H.; Dhagat, P.; Taratula, O. Multifunctional nanomedicine platform for concurrent delivery of chemotherapeutic drugs and mild hyperthermia to ovarian cancer cells. Int. J. Phrmaceut. 2013, 458, 169-180.
  • Taratula, O.; Schumann, C.; Naleway, M.A.; Pang, A.J.; Chon, K.J.; Taratula,O. A Multifunctional Theranostic Platform Based On Phthalocyanine-Loaded Dendrimer For Image-Guided Drug Delivery And Photodynamic Therapy. Mol. Pharmaceut. 2013, 10 3946-3958.
  • Shah, V., Taratula, O., Garbuzenko, O.B.; Taratula, O.R., Rodriguez-Rodriguez, L., Minko T. Targeted Nanomedicine for Suppression of CD44 and Simultaneous Cell Death Induction in Ovarian Cancer: an Optimal Delivery of siRNA and Anticancer Drug. Clin. Cancer Res. 2013, 19, 6193-6204.